Andrew Guggenhime

Mr. Andrew L.
Guggenhime is a Chairman at Caribou Biosciences, Inc. and a President & Chief Financial Officer at Vaxcyte, Inc. Mr. Guggenhime was previously employed as an Independent Director by Metacrine, Inc., a Chief Financial Officer by Dermira, Inc., a Chief Financial Officer by Calistoga Pharmaceuticals, Inc., a Chief Financial Officer & Senior Vice President by Abbott Biotherapeutics Corp., a Chief Financial Officer & Senior Vice President by PDL BioPharma, Inc., a Chief Financial Officer & Senior Vice President by Neoforma, Inc., a Vice President by Merrill Lynch & Co., Inc., and an Assistant VP-Real Estate Capital Markets Group by Wells Fargo & Co. He also served on the board at CardioDx, Inc. He received his undergraduate degree from Middlebury College and an MBA from Kellogg School of Management.